Literature DB >> 1590688

In vitro susceptibilities of the Bacteroides fragilis group to 14 antimicrobial agents in Korea.

K Lee1, I H Jang, Y J Kim, Y Chong.   

Abstract

The susceptibilities to 14 antimicrobial agents of 172 clinical isolates of the Bacteroides fragilis group from Korean patients during 1989 and 1990 were tested by an agar dilution method. All the isolates tested were susceptible to imipenem, chloramphenicol, and metronidazole. The rate of resistance to cefoxitin was 6%.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1590688      PMCID： PMC189253          DOI： 10.1128/AAC.36.1.195

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

Review 1.  Therapeutic implications of bacteriologic findings in mixed aerobic-anaerobic infections.

Authors:  S M Finegold; H M Wexler
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

Review 2.  Antimicrobial resistance in Bacteroides.

Authors:  H M Wexler; S M Finegold
Journal:  J Antimicrob Chemother       Date:  1987-02       Impact factor: 5.790

3.  Factors contributing to resistance to beta-lactam antibiotics in Bacteroides fragilis.

Authors:  B Olsson; K Dornbusch; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

4.  Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents.

Authors:  C Betriu; E Campos; C Cabronero; C Rodriguez-Avial; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

5.  Cefoxitin inactivation by Bacteroides fragilis.

Authors:  G J Cuchural; F P Tally; N V Jacobus; P K Marsh; J W Mayhew
Journal:  Antimicrob Agents Chemother       Date:  1983-12       Impact factor: 5.191

6.  Survey of anaerobic susceptibility patterns in Canada.

Authors:  A M Bourgault; G K Harding; J A Smith; G B Horsman; T J Marrie; F Lamothe
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

7.  Inactivation of cephalosporins by Bacteroides.

Authors:  F P Tally; J P O'Keefe; N M Sullivan; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

8.  Activity of newer beta-lactam agents against clinical isolates of Bacteroides fragilis and other Bacteroides species.

Authors:  J P O'Keefe; F R Venezio; C A DiVincenzo; K L Shatzer
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

9.  Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation.

Authors:  G J Cuchural; F P Tally; N V Jacobus; K Aldridge; T Cleary; S M Finegold; G Hill; P Iannini; J P O'Keefe; C Pierson
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

10.  Cefoxitin resistance to beta-lactamase: a major factor for susceptibility of bacteroides fragilis to the antibiotic.

Authors:  G Darland; J Birnbaum
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191
View more
  5 in total

1.  Susceptibilities of members of the Bacteroides fragilis group to 11 antimicrobial agents.

Authors:  R Horn; J Lavallée; H G Robson
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

2.  Plasmid-related resistance to cefoxitin in species of the Bacteroides fragilis group isolated from intestinal tracts of calves.

Authors:  F dos Santos Almeida; M J Avila-Campos
Journal:  Curr Microbiol       Date:  2006-10-03       Impact factor: 2.188

Review 3.  Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections.

Authors:  J A Balfour; H M Bryson; R N Brogden
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

4.  Longitudinal study of susceptibilities of species of the Bacteroides fragilis group to five antimicrobial agents in three medical centers.

Authors:  P Turgeon; V Turgeon; M Gourdeau; J Dubois; F Lamothe
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

5.  In vitro activity of FK037, a new parenteral cephalosporin, against anaerobic bacteria.

Authors:  N Kato; H Kato; Y Tanaka; K Bando; K Watanabe; K Ueno
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.